X4 Pharmaceuticals, Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

0.1872

-0.0141 (-7.00%)

At close: Apr 24, 2025, 4:00 PM

0.1616

-0.0256 (-13.68%)

Pre-market: Apr 25, 2025, 5:31 AM EDT

X4 Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Revenue	2.56	-	-	-	3	Upgrade
Cost of Revenue	0.8	-	-	-	-	Upgrade
Gross Profit	1.76	-	-	-	3	Upgrade
Selling, General & Admin	61.52	35.51	27.02	24.7	20.94	Upgrade
Research & Development	81.64	72.02	61.06	50.65	41.93	Upgrade
Operating Expenses	143.16	107.52	88.08	75.35	62.87	Upgrade
Operating Income	-141.4	-107.52	-88.08	-75.35	-59.87	Upgrade
Interest Expense	-8.77	-5.78	-3.99	-3.64	-2.69	Upgrade
Interest & Investment Income	5.77	4.58	0.22	0.01	0.27	Upgrade
Currency Exchange Gain (Loss)	-0.33	0	-	-	-4.37	Upgrade
Other Non Operating Income (Expenses)	2.59	7.63	-2.5	0.06	4.84	Upgrade
EBT Excluding Unusual Items	-142.14	-101.09	-94.35	-78.92	-61.82	Upgrade
Impairment of Goodwill	-	-	-	-9.76	-	Upgrade
Gain (Loss) on Sale of Assets	105	-	0.51	-	-	Upgrade
Other Unusual Items	-	-	-	-	-0.16	Upgrade
Pretax Income	-37.14	-101.09	-93.84	-88.68	-61.98	Upgrade
Income Tax Expense	0.31	0.08	0.03	0.02	0.15	Upgrade
Net Income	-37.45	-101.17	-93.87	-88.7	-62.13	Upgrade
Preferred Dividends & Other Adjustments	-	-	2.55	13.94	-	Upgrade
Net Income to Common	-37.45	-101.17	-96.41	-102.64	-62.13	Upgrade
Shares Outstanding (Basic)	201	178	64	26	20	Upgrade
Shares Outstanding (Diluted)	201	178	64	26	20	Upgrade
Shares Change (YoY)	13.08%	179.91%	146.71%	28.25%	74.13%	Upgrade
EPS (Basic)	-0.19	-0.57	-1.52	-3.99	-3.09	Upgrade
EPS (Diluted)	-0.19	-0.57	-1.52	-3.99	-3.09	Upgrade
Free Cash Flow	-131.23	-96.57	-77.21	-71.52	-60.18	Upgrade
Free Cash Flow Per Share	-0.65	-0.54	-1.22	-2.78	-3.00	Upgrade
Gross Margin	68.83%	-	-	-	100.00%	Upgrade
Operating Margin	-5529.96%	-	-	-	-1995.80%	Upgrade
Profit Margin	-1464.61%	-	-	-	-2071.03%	Upgrade
Free Cash Flow Margin	-5132.07%	-	-	-	-2006.00%	Upgrade
EBITDA	-140.61	-107.1	-87.57	-74.85	-59.52	Upgrade
D&A For EBITDA	0.8	0.42	0.51	0.5	0.35	Upgrade
EBIT	-141.4	-107.52	-88.08	-75.35	-59.87	Upgrade

Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q